These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 214713)

  • 1. Interferon inhibits the release of plasminogen activator from SV3T3 cells.
    Schroder EW; Chou IN; Jaken S; Black PH
    Nature; 1978 Dec 21-28; 276(5690):828-9. PubMed ID: 214713
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay of effects of interferon on plasminogen activator.
    Schroder EW; Black PH
    Methods Enzymol; 1981; 79(Pt B):336-42. PubMed ID: 6173681
    [No Abstract]   [Full Text] [Related]  

  • 3. Intracellular plasminogen activator activity in growing and quiescent cells.
    Loskutoff DJ; Paul D
    J Cell Physiol; 1978 Oct; 97(1):9-16. PubMed ID: 213444
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in intracellular distribution of plasminogen activator in growing, confluent, and transformed 3T3 cells.
    Jaken S; Black PH
    Proc Natl Acad Sci U S A; 1979 Jan; 76(1):246-50. PubMed ID: 284339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of macrophage migration inhibitory activity by plasminogen activators.
    Roblin RO; Hammond ME; Bensky ND; Dvorak AM; Dvorak HF; Black PH
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1570-4. PubMed ID: 193107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant secretion by transformed SVWI38-VA13-2RA cells of plasminogen activator(s) and substance (s) which prevent their detection.
    Roblin RO; Young PL; Bell TE
    Biochem Biophys Res Commun; 1978 May; 82(1):165-72. PubMed ID: 96833
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell density-dependent secretion of plasminogen activator by 3T3 cells.
    Chou IN; O'Donnell SP; Black PH; Roblin RO
    J Cell Physiol; 1977 Apr; 91(1):31-7. PubMed ID: 404303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibitory effect of mouse interferon in transformed cells.
    Borecký L; Hajnická V; Kontsek P; Lacković V; Russ G; Pĕknicová J; Capková J; Rajcáni J; Fuchsberger N
    Acta Microbiol Acad Sci Hung; 1981; 28(3):271-82. PubMed ID: 6171141
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of interferon in mouse cells infected with MuLV.
    Pitha PM
    Ann N Y Acad Sci; 1980; 350():301-13. PubMed ID: 6165284
    [No Abstract]   [Full Text] [Related]  

  • 10. New assay for the plasminogen activator activity of transformed cells.
    Mangel WF; Livingston DC; Brocklehurst JR; Liu HY; Peltz GA; Cannon JF; Leytus SP; Wehrly JA; Salter BL; Mosher JL
    Cold Spring Harb Symp Quant Biol; 1980; 44 Pt 1,():669-80. PubMed ID: 6448727
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased secretion of plasminogen activator by human macrophages after exposure to leukocyte interferon.
    Hovi T; Saksela O; Vaheri A
    FEBS Lett; 1981 Jul; 129(2):233-6. PubMed ID: 6169547
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissociation of plasminogen activator from the transformed phenotype in a 5-bromodeoxyuridine dependent mutant of Syrian hamster melanoma cells.
    Rosenthal SL; Zucker D; Davidson RL
    J Cell Physiol; 1978 Jun; 95(3):275-85. PubMed ID: 649664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the transformation-specific kinase in ASV-transformed cells by N-alpha-tosyl-L-lysyl chloromethyl ketone.
    Richert N; Davies PJ; Jay G; Pastan I
    Cell; 1979 Oct; 18(2):369-74. PubMed ID: 227606
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon inhibits the in vitro accumulation of virus specific RNA in nuclei isolated from SV40 infected cells.
    Metz DH; Oxman MN; Levin MJ
    Biochem Biophys Res Commun; 1977 Mar; 75(1):172-8. PubMed ID: 192228
    [No Abstract]   [Full Text] [Related]  

  • 15. MIF-like activity in simian virus 40-transformed 3T3 fibroblast cultures.
    Hammond ME; Roblin RO; Dvorak AM; Selvaggio SS; Black PH; Dvorak HF
    Science; 1974 Sep; 185(4155):955-7. PubMed ID: 4377757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium stimulation of plasminogen activator secretion/production by swiss 3T3 cells.
    Chou IN; Roblin RO; Black PH
    J Biol Chem; 1977 Sep; 252(18):6256-9. PubMed ID: 197085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon inhibits induction of endogenous murine leukemia virus production.
    Ramseur JM; Friedman RM
    Virology; 1976 Sep; 73(2):553-6. PubMed ID: 183371
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimessenger oligonucleotide for urokinase receptor gene inhibits invasivity of transformed human fibroblasts.
    Quattrone A; Fibbi G; Anichini E; Pucci M; Zamperini A; Capaccioli S; Del Rosso M
    Anticancer Drug Des; 1995 Jan; 10(1):97-102. PubMed ID: 7695815
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro differentiation of teratomas and the distribution of creatine phosphokinase and plasminogen activator in teratocarcinoma-derived cells.
    Topp W; Hall JD; Marsden M; Teresky AK; Rifkin D; Levine AJ; Pollack R
    Cancer Res; 1976 Nov; 36(11 Pt. 2):4217-23. PubMed ID: 184930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of fibrinolysin T activity fails to restore density-dependent growth inhibition to SV3T3 cells.
    Chou IN; Black PH; Roblin RO
    Nature; 1974 Aug; 250(5469):739-41. PubMed ID: 4370416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.